TGA approval of Kimmtrak

TGA

15 June 2022 - Tebentafusp is a bi-specific fusion protein.

Kimmtrak is indicated for the treatment of HLA-A*02:01 positive adult patients with unresectable or metastatic uveal melanoma.

Read TGA prescription medicine decision summary for Kimmtrak

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Outcome , Medicine , Australia